Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer.
about
Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapyChemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy.Chemotherapy-Related Neurotoxicity.Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study.Taxane-Induced Peripheral Neurotoxicity.Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review.Chronic Pain and Neuropathy Following Adjuvant Chemotherapy.Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group.Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial.Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer
P2860
Q33800180-55E8370B-BA99-4DCD-83A4-73E081D8C125Q38370562-6076C74B-8A66-4ECA-A8BB-3E5D4CE0D59CQ38700984-0F5EE6BD-9FCE-4D78-A4AF-950C0C2D5BA3Q38747276-64D8B5F3-B34B-49BE-B968-88B645C80480Q38904676-32A851F0-944F-43EC-B70D-B634F5BC5FFBQ39138091-F0A72E2E-A2F7-4CEC-A3CB-64B4B1757678Q41346602-F1D1ADE3-7EA8-4F93-9071-C58DDE6E1A84Q45759415-7A61E267-C85C-47CE-BC0C-6665718DA5CFQ45971033-D4C0FCBB-DAE7-45AC-B7BB-B5129135583DQ47894849-E7E86401-5052-46CE-8F65-1D88292D3D6EQ50229022-25973C72-20BF-49F3-8C2D-38633268F464Q55375369-2F5FA3C4-8BA8-4835-815C-E14AB3C50D9CQ57581249-7AF63EBB-1FB8-442F-84E8-65810B64540D
P2860
Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Risk of docetaxel-induced peri ...... ith early stage breast cancer.
@en
Risk of docetaxel-induced peri ...... ith early stage breast cancer.
@nl
type
label
Risk of docetaxel-induced peri ...... ith early stage breast cancer.
@en
Risk of docetaxel-induced peri ...... ith early stage breast cancer.
@nl
prefLabel
Risk of docetaxel-induced peri ...... ith early stage breast cancer.
@en
Risk of docetaxel-induced peri ...... ith early stage breast cancer.
@nl
P2093
P2860
P1476
Risk of docetaxel-induced peri ...... ith early stage breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1007/S10549-013-2728-2
P407
P50
P577
2013-10-17T00:00:00Z